On November 10, 2020 bluebird bio, Inc. (NASDAQ: BLUE) reported that members of the management team will participate in the following upcoming investor conferences (Press release, bluebird bio, NOV 10, 2020, View Source [SID1234570445]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Cowen 2020 IO Next Summit, Friday, November 13, at 11:15 am ET
Barclays Gene Editing & Gene Therapy Summit, Monday, November 16, at 7:45 am ET
To access the live webcasts of bluebird bio’s presentations, please visit the "Events & Presentations" page within the Investors & Media section of the bluebird bio website at View Source Replays of the webcasts will be available on the bluebird bio website for 90 days following the events.